OTIC Stock Forecast 2023, 2024, 2025, 2030
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.
The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States.
In contrast, Otonomy’s stock price is 19% more unpredictable than the S&P 500. When compared by MarketBeat users, Otonomy received 46 more exceed votes than Rockwell Medical. Similarly, 63.08% of people voted for Otonomy to outperform, whereas just 59.27% of users chose Rockwell Medical.
Nasdaq delists securities of Tuscan Holdings, Clovis Oncology … – Seeking Alpha
Nasdaq delists securities of Tuscan Holdings, Clovis Oncology ….
Posted: Wed, 28 Dec 2022 08:00:00 GMT [source]
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding.
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Technology, Consumer Services and Industrials sectors propelled shares higher. Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Financials and Basic Materials sectors propelled shares higher while losses in the Technology,… With the lowest OTIC earnings projection at -$48,580,467. And the highest OTIC stock forecast at -$22,289,861, three Wall Street analysts expect OTIC will make -$33,149,024 in 2023. As a result, if you paid $100 today, your investment could be worth nothing on December 1, 2023.
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OTIC quote. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
There are 12 OTIC stock forecast made for every month of 2026. Two Wall Street experts have predicted prices for OTIC for the next year; the average price target for OTIC is $3.25, with the greatest price target being $6.00 and the lowest being $0.50. A beta of 1.02 indicates that Rockwell Medical’s stock price is 2% more unpredictable than the S&P 500.
What is the P/E ratio for Otonomy stock?
It can also be https://1investing.in/ the company’s Market Cap by the Net Profit. Special Replay for The A.I. Predictive Power EventIf you missed The A.I. Predictive Power Event… don’t worry, for a limited time, we’ve made a replay available to the public. If you’re at or near retirement age, you don’t want to miss this… An-E’s predictions could help you make up any money you may have lost during the past 18 months and then some.
Shares in Otonomy are owned by institutions 80.1% of the time. Insiders of the business own 2.9% of the shares of Rockwell Medical. Comparatively, insiders of the firm own 9.1% of the shares of Otonomy. Endowments, big money managers, and hedge funds who own a significant portion of a stock typically do so because they feel it has the potential for long-term growth. And OTO-313, a prolonged formulation of the N-methyl-D-aspartate blocker gacyclidine, which is in Ii Clinical trials to treat tinnitus. OTIC stock continue to exist in the market with these developments.
See JSI’s FINRA BrokerCheck and Form CRS for further information. When you enable T-Bill investing on the Public platform, you open a separate brokerage account with JSI (the “Treasury Account“). An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. An indication of interest to purchase securities involves no obligation or commitment of any kind. You can find your newly purchased Otonomy stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, and alternative assets.
It indicates a way to close an interaction, or dismiss a notification. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. By creating a free account, you agree to our terms of service.
Moody’s Daily Credit Risk Score
In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The average OTIC stock forecast for 2031 is $1.01, with high predictions of $1.07 and low OTIC stock forecast of $0.93. There are 12 OTIC stock forecast made for each month of 2031. Twelve OTIC stock forecast are made to every month of 2028 for the OTIC stock forecast for 2028 , with an average prognosis of $0.99, a high prediction of $1.04, and a low prediction of $0.97. The average Otonomy stock projection for 2026 is $1.04, with the high predictions of $1.11 and low OTIC stock forecast of $0.95.
Before OTIC stock about the stock, let’s talk about the company. The biopharmaceutical business Otonomy, Inc. creates neurotology-related medications in the US. San Diego, California serves as the corporate headquarters for Otonomy, Inc., which was founded in 2008. The company provides OTO-413, a sustained-exposure preparation of brain-derived neurotrophic factor, which is in Phase IIa clinical trials for the treatment of speaking hearing difficulties. According to 3 analysts, the average rating for OTIC stock is “Hold.” The 12-month stock price forecast is $0.5, which is an increase of 107,900.00% from the latest price. Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC.
2 brokers have issued 1 year the best days of the week to trade forex objectives for Otonomy’s shares. Their OTIC share price forecasts range from $0.50 to $0.50. On average, they predict the company’s stock price to reach $0.50 in the next twelve months. This suggests a possible upside of 5,782.4% from the stock’s current price. View analysts price targets for OTIC or view top-rated stocks among Wall Street analysts. The average rating score is and is based on 1 buy ratings, 1 hold ratings, and 0 sell ratings.
What analysts recommend for OTIC stock, on a scale from 1 to 5. Since the price of Otonomy stock has been trending downward, we assume that similar segmentations were not very well-liked during the time frame. Our prediction method projects the stock’s future price to be $0 (-100%) after a year. Below are the latest news stories about OTONOMY INC that investors may wish to consider to help them evaluate OTIC as an investment opportunity. There are currently no analyst ratings available for Otonomy. Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with…
Furthermore, Otonomy has shown in preclinical research that the restoration of auditory function is connected to the repair of synaptic connections. Initial clinical investigations have shown that OTO-413 is well tolerated and enhances hearing performance in a number of clinically recognized speech-in-noise hearing tests after a single intratympanic injection. Otonomy Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear.
During the event, we even reveal An-E’s predictions of the stock prices of TSLA, NVDA, and AAPL for FREE. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. Discuss news and analysts’ price predictions with the investor community. In a Phase 2 clinical trial in people with tinnitus, Otonomy reported that OTO-313 showed no clinically marked improvement versus placebo for both the primary and secondary endpoints.
See Jiko U.S. Treasuries Risk Disclosures for further details. On August 13, 2014, Otonomy stock went public at a price of $17.15. Your return over the last eight years would be -98.96%, for an annualized return of -43.46%, if you had purchased Otonomy stock at $17.15. Compared to Otonomy, Rockwell Medical has larger revenue and earnings.
#JHGDriven Bo Butner No. 5 in the Pro Stock Points – Drag Illustrated
#JHGDriven Bo Butner No. 5 in the Pro Stock Points.
Posted: Sun, 02 Apr 2023 07:00:00 GMT [source]
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.
For Otonomy stock is no 52WeekLow data available or the value couldn’t be calculated because of a value to close/at 0.00. For Otonomy stock is no 52WeekHigh data available or the value couldn’t be calculated because of a value to close/at 0.00. The 2 analysts offering price forecasts for Otonomy have a median target of 3.25, with a high estimate of 6.00 and a low estimate of 0.50. 2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Otonomy in the last twelve months.
- According to 3 analysts, the average rating for OTIC stock is “Hold.” The 12-month stock price forecast is $0.5, which is an increase of 107,900.00% from the latest price.
- This indicates that you shouldn’t add this stock to your portfolio because trading in market downturns is always more difficult, especially for novice traders.
- Your return over the last eight years would be -98.96%, for an annualized return of -43.46%, if you had purchased Otonomy stock at $17.15.
- © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.
- The average rating score is and is based on 1 buy ratings, 1 hold ratings, and 0 sell ratings.
It also develops OTO-510, an otoprotectant for the pr… Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.
The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability – yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates.